Skip to content

Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil

Nutritional Anemia: Prevention and Treatment in Early Childhood

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00701246
Enrollment
196
Registered
2008-06-19
Start date
2005-04-30
Completion date
2006-03-31
Last updated
2014-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

Anemia, Iron deficiency anemia, Infants, Children, Clinical trials, Ferrous sulfate, Folic acid, Daycare centers, Anaemia in children, born at term, non-twins, with parental approval for participation in the study, growth

Brief summary

Iron deficiency anemia is the most common nutritional problem in the world. The objectives of this study are: * to evaluate the prevalence of anemia in children from 6 to 24 months of age and the therapeutic and prophylactic response to ferrous sulfate plus folic acid on hemoglobin levels. * to compare the effect of folic acid supplementation with ferrous sulfate on the linear and weight growth of anemic and non-anemic Study hypothesis: * The ferrous sulfate plus folic acid can improve the response on hemoglobin levels. * The folic acid supplementation with ferrous sulfate have effect on the linear and weight growth of anemic and non-anemic.

Detailed description

Purpose The objective of this study were: * to assess the prevalence of anemia and the therapeutic and prophylactic response to ferrous sulfate and folic acid. * to compare the effect of folic acid supplementation with ferrous sulfate on the linear and weight growth of anemic and non-anemic. A double-blind, randomized, controlled clinical trial was conducted with 196 children 6 to 24 months of age enrolled in municipal daycare centers in Goiânia, Goias State, Brazil. The children were assigned to two treatment groups that received a daily dose (5 times a week) of either 4.2mg/kg/day of ferrous sulfate + folic acid (50μg) or 4.2mg/kg/day of ferrous sulfate + folic acid placebo. One of the prevention groups received 1.4mg/kg/day of ferrous sulfate + folic acid (50μg/day) and the other 1.4mg/kg/day of ferrous sulfate + folic acid placebo. Supplementation lasted approximately three months.

Interventions

DRUGferrous sulfate
DRUGfolic acid

Sponsors

Federal University of São Paulo
CollaboratorOTHER
Ministry of Health, Brazil
CollaboratorOTHER_GOV
Goiania Municipal Health Department
CollaboratorUNKNOWN
Universidade Federal de Goias
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* from 6 to 24 months * born at term * non-twins * with parental approval for participation in the study * attending municipal daycare centers with mor than four children each

Exclusion criteria

* Children with special needs * low birth weight (\<2.500g) * with growth-impairing heart diseases * neurological syndromes * sickle-cell anemia * sickle-cell trait * under treatment for anemia at the time of the first interview or screening performed by the pediatrician * those no longer attending the daycare center * the clinical trial excluded children with hemoglobin \>=7 amd \<=8g/dL. * For the second objective: incomplete anthropometric surveys

Design outcomes

Primary

MeasureTime frame
Iron statusApproximately three months

Secondary

MeasureTime frame
Prevalence of anemiaApproximately three months

Other

MeasureTime frameDescription
Linear ad weight gain of anemic and non-anemicApproximately three monthsLinear and weight gain of anemic and non-anemic observed by anthropometric surveys (Z-score for weight-for-age, Z-score for height-for-age, Z-score for weight-for-height, average monthly weight, monthly length gain, and gain of Z-scores for weight-for-age, height-for-age, weight-for-height)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026